Takai S, Nakanishi N, Yokota I, Imai K, Yamada A, Kawasaki T, Okada T, Sawada T, Fujita H, Matoba S. Clot regression effects of rivaroxaban in the treatment of venous thromboembolism in patients with cancer (CRERIT-VTE cancer): study protocol. BMJ Open. 2019;9:e031698.